Alnylam Pharmaceuticals Inc Logo

Alnylam Pharmaceuticals Inc (1ALNY)

MTA

Currency in EUR
203.10
+2.90 (+1.45%)

Real-time Data

07:00 AM

Day's Range

195.95
203.10

52 wk Range

177.30
439.60

Analyst Ratings - 1ALNY - Alnylam Pharmaceuticals Inc

Analyst ratings

DateFirmActionRating
Aug 19, 2026BMO CapitalInitiates coverageOutperform
Aug 14, 2026Wells FargoMaintainsEqual-Weight
Aug 04, 2026Truist SecuritiesMaintainsBuy
Aug 04, 2026HC Wainwright & Co.MaintainsBuy
Aug 03, 2026Raymond JamesUpgradeOutperform → Strong Buy
Aug 03, 2026CitigroupMaintainsBuy
Aug 03, 2026BarclaysMaintainsOverweight
Jul 31, 2026JP MorganMaintainsOverweight
Jul 31, 2026RBC CapitalMaintainsOutperform
Jul 31, 2026Morgan StanleyMaintainsEqual-Weight
Items per row:

Estimates - 1ALNY - Alnylam Pharmaceuticals Inc

Estimate momentum

Current quarter · How the consensus estimate has moved over the last 90 days.

Revised last month0/0

EPS estimates

PeriodAnalystsLowAverageHighYear ago
Current quarter-----
Next quarter-----
Current year-----
Next year-----

Earnings History - 1ALNY - Alnylam Pharmaceuticals Inc

Estimate surprises

DateTimeEPS EstimateEPS ActualDifferenceSurprise PRC
2026-07-15-1.351.41+0.06‪+4.44%‬
2026-02-11-2.082.10+0.02‪+0.96%‬

The information on this page is provided for general informational purposes only and is not investment advice.

Market data provided by Twelve Data. Charting by TradingView.

Last updated:

Stocks news

Track Global Markets in Real Time with UA Finance

Download the app now and access live financial data, expert analysis, and trusted economic news to follow stocks, forex, gold, and cryptocurrencies with ease.